Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model

Cancer Immunology, Immunotherapy

Volumn 59, Issue 12, 2010, Pages 1801-1811

  Pinkhasov, Julia ^a   Alvarez, M Lucrecia ^a   Pathangey, Latha B ^b   Tinder, Teresa L ^b   Mason, Hugh S ^a   Walmsley, Amanda M ^a   Gendler, Sandra J ^b   Mukherjee, Pinku ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Cholera toxin B subunit; Epithelial mucin 1; MUC1 transgenic mouse model; Oral immunization; Tumor immunotherapy

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CPG OLIGODEOXYNUCLEOTIDE; MUCIN 1; RECOMBINANT INTERLEUKIN 12; AUTOANTIGEN; CHOLERA TOXIN; CPG-OLIGONUCLEOTIDE; INTERLEUKIN 12; OLIGODEOXYRIBONUCLEOTIDE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; C57BL 6 MOUSE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; HUMAN; IMMUNIZATION; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; NEOPLASMS, EXPERIMENTAL; TUMOR CELL LINE;

ANIMALS; AUTOANTIGENS; CELL LINE, TUMOR; CHOLERA TOXIN; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; MUCIN-1; NEOPLASMS, EXPERIMENTAL; OLIGODEOXYRIBONUCLEOTIDES;

EID: 77957654030     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0906-1     Document Type: Article

References (37)

1. R Dahiya KS Kwak JC Byrd S Ho WH Yoon YS Kim 1993 Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene Cancer Res 53 1437 1443 1:CAS:528:DyaK3sXksVKntLk%3D 8443822
2. Y Dong MD Walsh MC Cummings RG Wright SK Khoo PG Parsons MA McGuckin 1997 Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours J Pathol 183 311 317 1:CAS:528:DyaK2sXnvFaisbs%3D 10.1002/(SICI)1096-9896(199711)183: 3<311::AID-PATH917>3.0.CO;2-2 9422987 (Pubitemid 27505217)
3. X Leroy F Zerimech L Zini MC Copin MP Buisine B Gosselin JP Aubert N Porchet 2002 MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma Am J Clin Pathol 118 47 51 1:CAS:528:DC%2BD38Xlslyrsr4%3D 10.1309/1F99-BPDY-7DHH-9G97 12109855 (Pubitemid 34734251)
4. S Nakamori DM Ota KR Cleary K Shirotani T Irimura 1994 MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma Gastroenterology 106 353 361 1:STN:280:DyaK2c7jtFagsg%3D%3D 7905449
5. B Acres V Apostolopoulos JM Balloul D Wreschner PX Xing D Ali-Hadji N Bizouarne MP Kieny IF McKenzie 2000 MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines Cancer Immunol Immunother 48 588 594 1:CAS:528:DC%2BD3cXmsFSmtA%3D%3D 10.1007/PL00006677 10630311
6. RB Acres M Hareuveni JM Balloul MP Kieny 1993 Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen J Immunother Emphasis Tumor Immunol 14 136 143 1:CAS:528:DyaK2cXhs1Wjtro%3D 8280702
7. V Apostolopoulos PX Xing IF McKenzie 1994 Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens Cancer Res 54 5186 5193 1:CAS:528:DyaK2cXmt1ymurw%3D 7923138
8. T Gilewski S Adluri G Ragupathi S Zhang TJ Yao K Panageas M Moynahan A Houghton L Norton PO Livingston 2000 Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21 Clin Cancer Res 6 1693 1701 1:CAS:528:DC%2BD3cXktVWisrg%3D 10815887
9. JS Goydos E Elder TL Whiteside OJ Finn MT Lotze 1996 A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma J Surg Res 63 298 304 1:CAS:528:DyaK28XksVOms7k%3D 10.1006/jsre.1996.0264 8667619 (Pubitemid 26197209)
10. V Karanikas LA Hwang J Pearson CS Ong V Apostolopoulos H Vaughan PX Xing G Jamieson G Pietersz B Tait R Broadbent G Thynne IF McKenzie 1997 Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein J Clin Invest 100 2783 2792 1:CAS:528:DyaK2sXotVejsLc%3D 10.1172/JCI119825 9389743
11. BE Loveland A Zhao S White H Gan K Hamilton PX Xing GA Pietersz V Apostolopoulos H Vaughan V Karanikas P Kyriakou IF McKenzie PL Mitchell 2006 Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma Clin Cancer Res 12 869 877 1:CAS:528:DC%2BD28XhtFeiu78%3D 10.1158/1078-0432.CCR-05-1574 16467101 (Pubitemid 43259870)
12. P Mukherjee AR Ginardi TL Tinder CJ Sterner SJ Gendler 2001 MUC1-specific cytotoxic T lymphocytes eradicate tumors when adoptively transferred in vivo Clin Cancer Res 7 848s 855s 1:CAS:528:DC%2BD3MXjtFWks7g%3D 11300482
13. P Mukherjee CS Madsen AR Ginardi TL Tinder F Jacobs J Parker B Agrawal BM Longenecker SJ Gendler 2003 Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer J Immunother 26 47 62 1:CAS:528:DC%2BD3sXivFak 10.1097/00002371-200301000-00006 12514429 (Pubitemid 36056825)
14. P Mukherjee TL Tinder GD Basu LB Pathangey L Chen SJ Gendler 2004 Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model Breast Dis 20 53 63 1:CAS:528:DC%2BD2cXhtVahsLvP 15687707
15. J Taylor-Papadimitriou JM Burchell T Plunkett R Graham I Correa D Miles M Smith 2002 MUC1 and the immunobiology of cancer J Mammary Gland Biol Neoplasia 7 209 221 10.1023/A:1020360121451 12463741 (Pubitemid 38425494)
16. HA Vaughan DW Ho VA Karanikas CS Ong LA Hwang JM Pearson IF McKenzie GA Pietersz 1999 Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan-human MUC1 conjugates Vaccine 17 2740 2752 1:STN:280:DyaK1MzksFaltQ%3D%3D 10.1016/S0264-410X(98)00493-9 10418926 (Pubitemid 29314472)
17. J Xia Y Tanaka S Koido C Liu P Mukherjee SJ Gendler J Gong 2003 Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells J Immunol 170 1980 1986 1:CAS:528: DC%2BD3sXht12iurg%3D 12574367
18. S Zhang LA Graeber F Helling G Ragupathi S Adluri KO Lloyd PO Livingston 1996 Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice Cancer Res 56 3315 3319 1:CAS:528:DyaK28Xktlaqt70%3D 8764127
19. SM Pupa AM Invernizzi S Forti E Di Carlo P Musiani P Nanni PL Lollini R Meazza S Ferrini S Menard 2001 Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination Gene Ther 8 75 79 1:CAS:528:DC%2BD3MXpsFyitw%3D%3D 10.1038/sj.gt.3301360 11402305 (Pubitemid 32162419)
20. J Holmgren J Adamsson F Anjuere J Clemens C Czerkinsky K Eriksson CF Flach A George-Chandy AM Harandi M Lebens T Lehner M Lindblad E Nygren S Raghavan J Sanchez M Stanford JB Sun AM Svennerholm S Tengvall 2005 Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA Immunol Lett 97 181 188 1:CAS:528:DC%2BD2MXitFeru7o%3D 10.1016/j.imlet.2004.11.009 15752556 (Pubitemid 40326949)
21. JB Sun J Holmgren C Czerkinsky 1994 Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance Proc Natl Acad Sci USA 91 10795 10799 1:CAS:528:DyaK2MXitV2kur8%3D 10.1073/pnas.91.23.10795 7526379 (Pubitemid 24349571)
22. E Fan EA Merritt Z Zhang JC Pickens C Roach M Ahn WG Hol 2001 Exploration of the GM1 receptor-binding site of heat-labile enterotoxin and cholera toxin by phenyl-ring-containing galactose derivatives Acta Crystallogr D Biol Crystallogr 57 201 212 1:STN:280:DC%2BD3M3hsVantQ%3D%3D 10.1107/ S0907444900016814 11173465 (Pubitemid 32145398)
23. EA Merritt TK Sixma KH Kalk BA van Zanten WG Hol 1994 Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT) Mol Microbiol 13 745 753 1:CAS:528:DyaK2cXlslaltL8%3D 10.1111/j.1365-2958.1994. tb00467.x 7997185 (Pubitemid 24266209)
24. TK Sixma SE Pronk KH Kalk ES Wartna BA van Zanten B Witholt WG Hol 1991 Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli Nature 351 371 377 1:CAS:528:DyaK3MXksVCmsbc%3D 10.1038/351371a0 2034287
25. A George-Chandy K Eriksson M Lebens I Nordstrom E Schon J Holmgren 2001 Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells Infect Immun 69 5716 5725 1:CAS:528:DC%2BD3MXmsVarsb4%3D 10.1128/IAI.69.9.5716-5725.2001 11500448 (Pubitemid 32786510)
26. GJ Rowse RM Tempero ML VanLith MA Hollingsworth SJ Gendler 1998 Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model Cancer Res 58 315 321 1:CAS:528:DyaK1cXntF2gtQ%3D%3D 9443411
27. M Marinaro PN Boyaka FD Finkelman H Kiyono RJ Jackson E Jirillo JR McGhee 1997 Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses J Exp Med 185 415 427 1:CAS:528:DyaK2sXhtFWnsL4%3D 10.1084/jem.185.3.415 9053442 (Pubitemid 27078360)
28. Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S, Haga S, Kiyozuka Y, Schol D, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Kenemans P, Blockzjil A, Nilsson K, Nilsson O, Reddish M, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker MB, Hilgers J et al (1998) Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, CA, USA, 17-23 November 1996. Tumour Biol 19(Suppl 1):1-20
29. PX Xing JJ Tjandra SA Stacker JG Teh CH Thompson PJ McLaughlin IF McKenzie 1989 Monoclonal antibodies reactive with mucin expressed in breast cancer Immunol Cell Biol 67 Pt 3 183 195 10.1038/icb.1989.29 2477330
30. N Matoba BC Geyer J Kilbourne A Alfsen M Bomsel TS Mor 2006 Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate Vaccine 24 5047 5055 1:CAS:528:DC%2BD28XltF2rtrg%3D 10.1016/j.vaccine.2006.03.045 16621185 (Pubitemid 43782685)
31. R Rappuoli M Pizza G Douce G Dougan 1999 Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins Immunol Today 20 493 500 1:CAS:528:DyaK1MXmvVKhsL4%3D 10.1016/S0167-5699(99)01523-6 10529776 (Pubitemid 29507092)
32. NA Williams TR Hirst TO Nashar 1999 Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic Immunol Today 20 95 101 1:CAS:528:DyaK1MXhvVWhs7g%3D 10.1016/S0167-5699(98)01397-8 10098329 (Pubitemid 29136635)
33. YI Kawamura R Kawashima Y Shirai R Kato T Hamabata M Yamamoto K Furukawa K Fujihashi JR McGhee H Hayashi T Dohi 2003 Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation Eur J Immunol 33 3205 3212 1:CAS:528:DC%2BD3sXovFKnu7k%3D 10.1002/eji.200324135 14579289 (Pubitemid 37428353)
34. DM Klinman D Currie I Gursel D Verthelyi 2004 Use of CpG oligodeoxynucleotides as immune adjuvants Immunol Rev 199 201 216 1:CAS:528:DC%2BD2cXltFygsLY%3D 10.1111/j.0105-2896.2004.00148.x 15233736 (Pubitemid 38736773)
35. J Baines E Celis 2003 Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides Clin Cancer Res 9 2693 2700 1:CAS:528:DC%2BD3sXlt1yrs7k%3D 12855649
36. FG Snijdewint S von Mensdorff-Pouilly AH Karuntu-Wanamarta AA Verstraeten PO Livingston J Hilgers P Kenemans 2001 Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients Int J Cancer 93 97 106 1:CAS:528:DC%2BD3MXksFanurc%3D 10.1002/ijc.1286 11391628 (Pubitemid 32539508)
37. S von Mensdorff-Pouilly AA Verstraeten P Kenemans FG Snijdewint A Kok GJ Van Kamp MA Paul PJ Van Diest S Meijer J Hilgers 2000 Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin J Clin Oncol 18 574 583